We have employed a neutral-pH extraction technique to look for inositol 1,2-cyclic phosphate derivatives in [3H]inositol-labelled parotid gland slices stimulated with carbachol. The incubations were terminated by adding cold chloroform/methanol (1: 2, v/v), the samples were dried under vacuum and inositol phosphates were extracted from the dried residues by phenol/chloroform/water partitioning. Water-soluble inositol metabolites were separated by h.p.l.c. at pH 3.7. 32P-labelled inositol phosphate standards (inositol 1-phosphate, inositol 1,2-cyclic phosphate, inositol 1,4,5-trisphosphate and inositol 1,2-cyclic 4,5-trisphosphate) were quantitively recovered through both extraction and chromatography steps. Treatment of inositol cyclic phosphate standards with 5% (w/v) HC104 for 10 min prior to chromatography resulted in formation of the expected non-cyclic compounds.
INTRODUCTION
Phosphatidylinositol 4,5-bisphosphate [Ptdlns(4,5)P2] is a membrane-bound phospholipid that is the source of at least two intracellular signal molecules. Activation of a variety of cell surface receptors, such as the muscarinic cholinergic receptor of rat parotid glands (Schramm & Selinger, 1975) , stimulates a phosphoinositidase C (PIC) whose primary substrate appears to be PtdIns(4,5)P2 Berridge, 1983; Downes & Wusteman, 1983; Aub & Putney, 1984; Hawkins et al., 1986) . The lipid product of this reaction is 1,2-diacylglycerol and there is general agreement that its accumulation in the plasma membrane causes translocation of protein kinase C from an inactive form in the cytosol to give an active membrane-associated complex (Nishizuka, 1984) . However, there is now considerable controversy regarding the precise nature of the watersoluble product of PIC-catalysed Ptdlns(4,5)P2 breakdown.
Both membrane-bound and soluble PIC activities have been documented in mammalian cells (Allan & Michell, 1978; Irvine, 1982) , though it is not yet known to what extent each of these enzymes contributes to receptor-controlled PtdIns(4,5)P2 hydrolysis. The relatively high activity and ease of study of the soluble activity have, however, meant that most detailed work has utilized this form of the enzyme(s). The early experiments of Dawson & Clarke (1972) demonstrated that the rat brain cytosol enzyme(s) could degrade phosphatidylinositol (Ptdlns) to 1,2-diacylglycerol and a mixture of inositol 1-phosphate (InslP) and inositol 1,2-cyclic phosphate (Insl, 2cycP) , with the proportions of these two water-soluble products depending upon the pH of the incubation medium. Irvine et al. (1984a) later found that the soluble enzyme could attack phosphatidylinositol 4-phosphate (PtdIns4P) and PtdIns(4,5)P2 as well as Ptdlns, with the preferred substrate being determined by the precise conditions of the assay, but they did not assess whether cyclic phosphate derivatives of the inositol bis-and tris-phosphates were products of these reactions.
Majerus and his colleagues have since made two important contributions to the study of soluble PIC. First, they confirmed, using a purified enzyme from ram seminal vesicles, the multiple substrate specificity noted above (Wilson et al., 1984) , and secondly, they found two water-soluble products when Ptdlns(4,5)P2 was the substrate (Wilson et al., 1985a) . These products were Ins(1,4,5)P3 and inositol 1,2-cyclic 4,5-trisphosphate [Ins(1,2cyc4,5)P3].
The previous studies, which pointed to PtdIns(4,5)P2 as the primary target for receptor-dependent PIC, used acid-extraction techniques that would have destroyed the cyclic phosphodiester bond, so it was not known to what extent the cyclic and non-cyclic forms of inositol Vol. 243 Abbreviations used: InsP, InsP2, InsP3, InsP4, inositol mono-, bis-, tris-and tetrakis-phosphates; locants where specified are placed in parentheses, e.g. Ins(1,2cyc4,5)P3 is inositol 1,2-cyclic 4,5-trisphosphate; the D isomers are assumed throughout; PtdIns, PtdIns4P, PtdIns(4,5)P2, phosphatidylinositol and its 4-mono-and 4,5-bis-phosphates; PIC, phosphoinositidase C. trisphosphate were generated during agonist stimulation. If they were produced within cells, either or both of these compounds could have second messenger functions, since Ins(1,4,5)P3 has been shown to release Ca2+ from the intracellular stores of many different cells (Berridge & Irvine, 1984) and the cyclic derivative has similar activity and potency to Ins(1,4,5)P3 when added to permeabilized platelets and when injected into Limulus photoreceptors (Wilson et al., 1985b) . We have now used a neutral-pH extraction technique to assess whether inositol cyclic phosphates are formed during muscarinic cholinergic stimulation of parotid gland slices.
MATERIALS AND METHODS

Materials
Materials and animals were of the type and from the source specified previously (Downes et al., 1986a; Hawkins et al., 1986) . Phenol (analytical grade reagent) was purchased from BDH. Isoamyl alcohol (3-methylbutan-l-ol, 98%) was purchased from Aldrich. Preparation and incubation of parotid slices Rat parotid slices were prepared and incubated with [3H]inositol (3) (4) uCi/250 , ul) for 90 min at 37°C, as described by Downes et al. (1986a) . Small incubations (250 1l) were then challenged with either carbachol (1O /zl, 1 mm final concn.) or Krebs/Hepes buffer (Downes et al., 1986a) (250 ,ul) were terminated by addition of 10% (v/v) HC104 (250 j1l) on ice. HC104 was then removed from these samples by extraction with tri-n-octylamine and the [3H]inositol phosphates were analysed by anion-exchange chromatography on AG-1 (X8, 200-400 mesh, formate form) columns, as described by Downes et al. (1986a) .
Anion-exchange chromatography of inositol phosphates
In experiments where analysis of inositol phosphate isomers and their cyclic phosphate derivatives was required (see the Results section), inositol phosphates were separated by h.p.l.c. on Whatman Partisil 10 SAX, using a gradient ofincreasing concentration ofammonium formate/phosphoric acid (pH 3.7), as described by Batty et al. (1985) and Hawkins et al. (1986) . In the remaining experiments (see the Results section), inositol phosphates were separated on small AG-I (X8, 200-400 mesh, formate form) columns using batch elution with increasing concentrations of ammonium formate/formic acid (Downes et al., 1986a) .
Acid-catalysed hydrolysis of cyclic inositol phosphates to their non-cyclic derivatives
The samples containing inositol cyclic phosphates were incubated with 5 % (v/v) HC104 at 25°C for 10 min. Incubations were neutralized by addition of an equal volume of tri-n-octylamine/Freon (in the proportion 1:1, v/v) (Downes et al., 1986a) . After vigorous mixing, the resulting three phases were separated by bench centrifugation and an aliquot of the upper phase (pH approx. 7) taken for analysis by anion-exchange h.p.l.c. (see above).
Preparation of 32P-labelled erythrocyte membranes
Human erythrocytes were incubated with [32P]Pi as described by Downes et al. (1982) and Hawkins et al. (1986) . 32P-labelled membranes were prepared from these cells by lysis and washing in 20 mM-Tris/HCl (pH 7.2)/ 1 mM-EDTA .
Preparation of radioactive inositol phosphate standards [32P]Ins(1,4,5)P3 and [32P]Ins(1,2cyc4,5)P3 were prepared from 32P-labelled erythrocyte membranes by Ca2+-activation of the endogenous PIC . PIC was activated by incubating packed membranes (50 ml) in 20 mM-Tris/acetate (pH 5.5)/ 1 mM-CaCl2 for 30 min at 37 'C. The incubation was terminated by addition of 4 vol. of ice-cold 2.0 mM-EDTA (pH 7.0) and the membranes were pelleted by centrifugation (15 min at 12000 g). The supernatant was applied to two 0.6 ml AG-I (X8, 200-400 mesh, formate form) columns and InsP3 was separated from InsP2 and Pi by elution with batches of increasing concentrations of ammonium formate/formic acid (Downes et al., 1986a) . The column eluate containing InsP3 was neutralized by addition of triethylamine and the ammonium formate was removed by a LiCl desalting technique (Grado & Ballou, 1961) . This involved addition of a 1: 5 dilution (in water) of the eluate to a 200 4t1 Ag-I (X8, 200-400 mesh, hydroxide form) column, with InsP3 being eluted with 1 M-LiCl (3 ml). The LiCl eluate was dried in vacuo and the LiCl removed by repeated washing of the dried residue with dry ethanol. The Li+ salts of the inositol cyclic and non-cyclic trisphosphates were then separated by anion-exchange chromatography on a preparative h.p.l.c. column (25 cm x 2.2 cm), as described above; the minor peak (retention time of 23.25 min, 8-12%) being
[32P]Ins(1,2cyc4,5)P3 and the major peak (retention time of 25.0 min, 88-92% ) being [32P]Ins(1,4,5)P3.
[32P]InslP and [32P]Ins(1,2cyc)P were prepared by PIC-catalysed hydrolysis of [32P]Ptdlns (Dawson et al., 1971; Dawson & Clarke, 1972 (Folch, 1949) , emulsified with 10 mM-Tris/maleate buffer (pH 5.5), and incubated at 37°C for 60 min with 1 mM-CaCl2 and a rat liver supernatant (200000 g, 10 min) which had been dialysed against this buffer overnight. The incubation was terminated with 3.75 vol. of chloroform/methanol (1:2, v/v), additional chloroform and water were added to give two phases (Bligh & Dyer, 1959) , and the water-soluble products in the upper phase were separated by high voltage paper electrophoresis in pyridine/acetic acid (pH 3.5). Two 32P-labelled compounds with the appropriate mobilities relative to Pi of InsIP and Ins(1,2cyc)P (Dawson et al., 1971) were obtained. Confirmation of the identities of these two compounds was achieved by acid-catalysed hydrolysis of the [32P]Ins(1,2cyc)P (see above); analysis of the products by h.p.l.c. demonstrated the disappearance of [32P]Ins(1,2cyc)P, with the appearance of a single 32P-labelled peak that co-chromatographed with [32P]InslP (see the Results section). The structure of Ins(1 ,2cyc)P was originally deduced from the observation that acid-catalysed hydrolysis of this compound yielded both InsIP and Ins2P (Dawson et al., 1971 Preparation of parotid homogenates The parotid glands from two male rats (180-200 g) were dissected and homogenized in 8 ml of icecold 250 mM-sucrose/50 mM-Tris/HCl (pH 7.4)/1 mm-EGTA, containing 50 /tM-phenylmethanesulphonyl fluoride, 1 ,tg of leupeptin/ml and 10 mg of bovine serum albumin/ml, as described by Hawkins et al. (1986) . The homogenate was stored on ice and used within 30 min of preparation. Measurement of the rate of hydrolysis of Ins(1,4,5)P3 and Ins(1,2cyc4,5)P3 by a parotid homogenate Samples of 32P-labelled Ins(1,4,5)P3 and Ins(1,2cyc4,5)P3 were incubated, in parallel, with 70 mM-potassium glutamate/40 mM-NaCl/ 10 mM-Hepes/ NaOH (pH 7.2)/4 mM-MgSO4 and a 2.5-fold dilution of a parotid homogenate, prepared as described above. Incubations were at 30°C, and were terminated after various lengths of time (see the Results section) by addition of an equal volume of ice-cold 10% HClO4.
HC104 was removed by extraction with tri-n-octylamine/ Freon (Downes et al., 1986a) and the [32P]inositol phosphates were separated by chromatography on small AG-I columns (Downes et al., 1986a) . Measurement of the rate of phosphorylation of Ins(1,4,5)P3 and Ins(1,2cyc4,5)P3 by a parotid homogenate Samples of 32P-labelled Ins(1,4,5)P3 and Ins-(1,2cyc4,5)P3 were incubated with a 3.3-fold dilution of a parotid homogenate in an identical manner to that described above for measurement of InsP3 hydrolysis, except that 4 mM-MgSO4 was replaced with 10 mMMgATP. Incubations were terminated and the [32P]inositol phosphates analysed as described immediately above.
RESULTS
Neutral-pH extraction of inositol phosphates
The purpose of this study was to look for the stimulated accumulation of acid-labile inositol cyclic phosphates in parotid glands. The first step was, therefore, the development of a method for the extraction of inositol phosphates from tissues which avoided the use of low pH. We chose a method based on the mixing of tissue residues with phenol (see the Materials and methods section), since it is widely used as an effective method for the extraction of polar nucleotides (Slater et al., 1973 (Fig. la) , or after acid-catalysed hydrolysis of any inositol cyclic phosphates present (Fig. lb) Hawkins et al., 1986) . We therefore assessed the stability of cyclic inositol phosphate standards during chromatography on h.p.l.c. columns eluted exactly as described previously (see Hawkins et al., 1986) . The results were identical with those shown in Fig. 1(a) [3H]Inositol-labelled parotid gland slices were incubated with a supramaximal dose of carbachol (1 mM) for 5 s or 5 min. The incubations were terminated by addition of cold chloroform/methanol (1:2, v/v) as described in the Materials and methods section. 32P-labelled inositol phosphate standards were added at this point and the final tissue extracts, containing [3H]inositol-labelled parotid gland metabolites and 32P-labelled standards, were divided into two equal portions. One portion of each sample was analysed directly by anion-exchange h.p.l.c. and the other portion was acid-treated before analysis (see the Materials and methods section). Fig. 1(a) shows the h.p.l.c. profile obtained for a single sample that had been stimulated with carbachol for 5 s and includes four 32P-labelled peaks with the appropriate retention times for Ins(1,2cyc)P, InsIP, Ins(1,2cyc4,5)P3 and Ins(1,4,5)P3 (in order of elution). Both cyclic and non-cyclic standards were quantitatively recovered through the extraction and chromatography steps. The average recovery for all standards from nine tissue samples and 18 h.p.l.c. runs was 88+5% (acid-treated samples) and 106 + 3 % (not acid-treated).
[3H]Inositol-labelled compounds that co-chromatographed precisely with standard InsIP and Ins(1,4,5)P3 were observed in 18 separate h.p.l.c. runs. By contrast, none of the samples contained a 3H-labelled compound that corresponded to Ins(l, 2cyc4, 5) P3. This is illustrated in Fig. 1(a) where the centre, of the 32P-labelled Ins(1,2cyc4,5)P3 peak corresponds to background radioactivity in the 3H window. We estimate that
[3H]Ins(1,2cyc4,5)P3 would have been detected if it amounted to more than 500 of the peak value for [3H]Ins(1,4,5)P3. The occurrence of [3H]Ins(1,2cyc)P was more difficult to analyse because the standard was eluted in a region of the chromatogram that contained a complex 3H peak, and it was not possible to say whether this peak contained a compound with identical chromatographic properties to the standard. Other peaks marked on the Figure have been identified in previous studies (Irvine et al., 1984b; Hawkins et al., 1986) . Of particular relevance to the present experiments, Ins(1,3,4)P3 was identified as the major trisphosphate in parotid glands after prolonged stimulation with carbachol (Irvine et al., 1984b) . This compound elutes approx. 1.5 min before Ins(1,4,5)P3 and partially overlaps the Ins(l,2cyc4,5)P3 standard. However, it is clearly distinguishable from the cyclic trisphosphate because its peak elutes 0.5 min (two fractions) after the 32P-labelled standard and because it is not affected by acid treatment (see below and Fig. lb) .
Samples that were acid-treated before h.p.l.c. analysis (Fig. lb) were characterized by the occurrence of only two major 32P-labelled peaks, corresponding to the InsIP and Ins(1,4,5)P3 peaks in Fig. l(a) . Acid-catalysed hydrolysis of the 1,2-cyclic phosphate derivatives would be expected to yield inositol phosphates with phosphate groups in the 1 or 2 positions. This appears to be the case for the cyclic trisphosphate (see the Materials and methods section), but a single inositol monophosphate peak was obtained with the retention time of Ins1P. We suggest that InsIP and Ins2P are not separated under these chromatographic conditions. There was, however, very little difference between the [3H]inositol-labelled profiles in Figs. l(a) and l(b), indicating that inositol cyclic phosphate derivatives make little or no contribution to the water-soluble inositol metabolites in parotid glands.
Some 3H-labelled peaks remain unidentified at present, but may correspond to compounds such as Ins4P, which has been identified as a product of Ins(I ,4)P2 metabolism (Storey et al., 1985) , and Ins(3,4)P2 and Ins(1,3)P2, which we have found to be products of Ins(1,3,4)P3 hydrolysis is parotid gland homogenates (P. T. Hawkins, A. Morris & C. P. Downes, unpublished work). Of particular note is the unidentified 3H-labelled peak marked A in Figs. 1(a)  and 1(b) . This compound is not seen in HC104 extracts of 3H-labelled parotid slices (compare with Hawkins et al., 1986 ), but appears in extracts prepared from slices terminated by addition of neutral chloroform/methanol and extracted with either phenol (see the Materials and methods section) or a standard Bligh & Dyer (1959) phase partition (results not shown). It runs approx. 1 min later than [32P]glycerophosphoinositol 4,5-bisphosphate on our h.p.l.c. system (results not shown), it is not acid-labile (compare Figs. la and lb) and its levels appear unaffected by stimulation of parotid slices with 1 mM-carbachol. Table 1 shows the combined results for control and carbachol-stimulated samples in which we determined the levels of [3H]InslP and [3H]Ins(1,4,5)P3. We have concentrated on these two compounds because they are the only ones for which there is a corresponding 32P-labelled standard in each chromatogram. As noted in previous studies , increased sharply within 5 s of carbachol stimulation and remained elevated at 5 min. InsIP, on the other hand, showed no change after 5 s, but had increased substantially after 5 min exposure to carbachol. This demonstrates that the carbachol-induced effects on the levels of these compounds are not an artefact caused by the use of acid extraction conditions. Not only was there no evidence for Ins(1,2cyc4,5)P, in samples that had been stimulated for 5 s (Figs. la and lb), but there was also no evidence for the occurrence of this compound in control samples nor for its accumulation during prolonged (5 min) exposure to the agonist. This is illustrated in Table 1 by the failure of acid treatment to increase significantly the amount of radioactivity associated with the peak of Ins(1,4,5)P,. Ptdlns(4, 5) P2 is likely to be the primary target for the muscarinic receptor-activated PIC and that a similar mechanism is likely to operate for both a, and substance P receptors present on these cells (Downes & Wusteman, 1983; Aub & Putney, 1984 (Hawkins et al., 1986) , and their accumulation to much higher levels than Ins(1,4,5)P3 can be accounted for by their much slower rates of metabolism (Downes & Wusteman, 1983; Irvine et al., 1985) . Dixon & Hokin (1985) have identified Ins(1,2cyc)P in caerulein-stimulated pancreatic mini-lobules. This compound appeared to accumulate at a slow rate yet, even after prolonged stimulation, comprised only a small proportion of the total inositol phosphates. Such levels of the cyclic monophosphate would not have been detected in our experiments because of the presence of acid-stable [3H]inositol-containing compounds that eluted in the same part of the gradient as Ins(1,2cyc)P. As suggested by Dixon & Hokin (1985) , their results may indicate a relatively slow rate of hydrolysis of Ptdlns to InsIP and Ins(1 ,2cyc)P in exocrine pancreas, but the significance of such a reaction as a response of the glands to agonists is unknown, since it would not be expected to contribute significantly to diacylglycerol formation and no function has yet been found for the cyclic or non-cyclic monophosphate.
An essential feature of second messengers is that they should be rapidly metabolized so that their potent intracellular effects can be efficiently reversed. Indeed, the discovery ofan enzyme that specifically dephosphorylated Ins(1,4,5)P3 to Ins(1,4)P2 was an important clue to the likely importance of Ins(1,4,5)P3 (Downes et al., 1982) . More recently a second route for metabolism of Ins(1,4,5)P3, involving ATP-dependent phosphorylation to Ins(1,3,4,5)P4, has been described (Irvine et al., 1986; Hawkins et al., 1986) . Both pathways are catalysed by parotid gland homogenates, but Ins(1,2cyc4,5)P3 is a very poor substrate for endogenous phosphatases or kinases compared with the rapid metabolism of the non-cyclic compound. These results contrast with previous observations showing that Ins(1,2cyc4,5)P3 is a substrate for a phosphatase in a platelet cytosol fraction (Connolly et al., 1986) and for a kinase in rat brain cytosol (Irvine et al., 1986) . However, both these groups used high concentrations of Ins(1,4,5)P3 and Ins(1,2cyc4,5)P3 and may not have detected differences in their rates of metabolism due to a difference in the Km values of the relevant enzymes for the cyclic and non-cyclic substrates.
Both cytosolic (Dawson & Clarke, 1972 ) and membrane-bound PICs (see the Material and methods section and Irvine et al., 1986) can generate inositol cyclic phosphates during hydrolysis of inositol phospholipids in vitro, but the cyclic derivatives do not contribute significantly to the large increases in water-soluble inositol metabolites in carbachol-stimulated parotid glands. As noted in the Materials and methods section, 8-12 % of the InsP3 obtained when human erythrocyte membranes were incubated with Ca2+ at pH 5.5 was Ins(1,2cyc4,5)P3. However, it should be noted that the Ca2+ concentration used to activate the erythrocyte enzyme in vitro was approx. 1000 times greater than the Ca2+ concentration attained in carbachol-stimulated parotid gland acinar cells (Downes et al., 1986b) . Furthermore, low pH is known to favour the formation of Ins(1,2cyc)P from Ptdlns (Dawson & Clarke, 1972) but the pH within healthy cells is more likely to be close to 7.4 rather than 5.5.
The situation is further complicated by the occurrence of multiple forms of PIC in some tissues (Low & Weglicki, 1983 : Hirasawa et al., 1982 , raising the possibility that some forms of PIC, but not others, could yield inositol cyclic phosphates. There is a clear need to examine the products generated by these and other forms of PIC in a wide variety of tissues, and to compare these results with the spectrum of inositol phosphates that accumulate during agonist stimulation. An important goal will be the elucidation of assay conditions that accurately reflect the control of PIC in the cell by receptors and GTP-dependent regulatory proteins (see Downes & Michell, 1985 , for review).
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